Heron Therapeutics Inc. (HRTX)
NASDAQ: HRTX
· Real-Time Price · USD
1.33
-0.02 (-1.48%)
At close: Aug 15, 2025, 3:59 PM
1.33
-0.23%
After-hours: Aug 15, 2025, 05:03 PM EDT
Heron Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 16.52M | 19.27M | 25.8M | 25.74M | 18.39M | 20.45M | 28.68M | 34.86M | 13.46M | 27.09M | 15.36M | 50.44M | 48.61M | 56.91M | 90.54M | 159.57M | 191.17M | 59.74M |
Short-Term Investments | 24.12M | 31.41M | 33.48M | 45.15M | 48.96M | 51.07M | 51.73M | 42.55M | 19.78M | 32.93M | 69.49M | 71.31M | 34.93M | 55M | 67.04M | 43.25M | 66.5M | 106.73M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 6.08M | 6.28M | 6.48M | 6.71M | 6.93M | 7.88M | 8.13M | 8.37M | 8.58M | 14.14M | 15.71M | 17.32M | 17.53M | 17.98M | 17.72M | 346K | 346K | 346K |
Receivables | 79.93M | 78.74M | 78.88M | 67.04M | 73.71M | 65.32M | 60.14M | 63.8M | 76.69M | 51.45M | 52.05M | 42.19M | 40.3M | 41.1M | 35.5M | 43.09M | 42.62M | 38.52M |
Inventory | 72.97M | 56.93M | 53.16M | 45.95M | 42.86M | 42.47M | 42.11M | 42.01M | 44.62M | 52.06M | 54.57M | 52.24M | 61.32M | 56.47M | 48.38M | 41.5M | 42.8M | 42.63M |
Other Current Assets | 17.39M | 26.49M | 17.69M | 11.31M | 7.25M | 6.58M | 6.12M | 10.77M | 10.72M | 14.63M | 13.96M | 7.63M | 9.05M | 13.11M | 12.96M | 27.64M | 23.73M | 24.67M |
Total Current Assets | 210.92M | 212.84M | 209.01M | 195.19M | 191.17M | 185.9M | 188.77M | 193.98M | 165.28M | 178.16M | 205.44M | 223.8M | 194.21M | 222.59M | 254.42M | 315.05M | 366.83M | 272.29M |
Property-Plant & Equipment | 15.08M | 16.63M | 17.65M | 18.88M | 20.04M | 24.1M | 25.6M | 26.85M | 27.36M | 28.58M | 29.8M | 30.82M | 32.22M | 33.15M | 33.56M | 36.99M | 37.08M | 38.3M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 21.17M | 22.91M | 24.13M | 25.59M | 26.97M | 31.98M | 33.73M | 35.22M | 35.94M | 42.72M | 45.52M | 48.15M | 49.76M | 51.13M | 51.28M | 37.34M | 37.42M | 38.64M |
Total Assets | 232.09M | 235.75M | 233.15M | 220.78M | 218.14M | 217.89M | 222.51M | 229.2M | 201.22M | 220.88M | 250.95M | 271.95M | 243.97M | 273.72M | 305.71M | 352.39M | 404.25M | 310.93M |
Account Payables | 12.04M | 12.33M | 11.71M | 10.19M | 10.23M | 837K | 3.24M | 1.86M | 1.96M | 4.07M | 3.23M | 6.55M | 13.8M | 8.23M | 3.8M | 5.88M | 11.24M | 1.69M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.42M | n/a | n/a | n/a |
Short-Term Debt | 176.74M | n/a | n/a | n/a | 3.19M | 3.14M | 3.08M | 3M | 2.58M | 2.76M | 2.69M | 2.62M | 2.55M | 2.48M | 2.42M | 3.25M | 3.16M | 10.64M |
Other Current Liabilities | 63.35M | n/a | 7.96M | n/a | 56.62M | 60.62M | 61.07M | 61.51M | 69.75M | 58.8M | 59.96M | 67.38M | 74.27M | 67.59M | 47.09M | 43.9M | 50.9M | 75.88M |
Total Current Liabilities | 258.6M | 88.56M | 91.46M | 85.54M | 80.32M | 75.38M | 79.69M | 79.75M | 86.72M | 77.9M | 82.36M | 93.88M | 109.5M | 93M | 71.06M | 72.3M | 82.14M | 100.92M |
Long-Term Debt | n/a | 174.97M | 174.73M | 174.47M | 174.23M | 173.99M | 173.75M | 173.46M | 149.39M | 149.34M | 149.28M | 149.23M | 149.18M | 149.13M | 149.08M | 149.03M | 148.98M | n/a |
Other Long-Term Liabilities | 747K | 682K | 615K | 241K | 241K | 241K | 241K | 241K | 241K | 241K | 241K | 241K | 241K | 241K | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 747K | 175.65M | 175.34M | 175.24M | 175.76M | 176.28M | 176.79M | 177.24M | 153.79M | 154.41M | 155.02M | 155.63M | 156.2M | 156.76M | 157.08M | 161.25M | 162M | 13.79M |
Total Liabilities | 259.35M | 264.2M | 266.8M | 260.78M | 256.08M | 251.65M | 256.48M | 256.99M | 240.51M | 232.31M | 237.38M | 249.5M | 265.7M | 249.76M | 228.14M | 233.54M | 244.14M | 114.71M |
Total Debt | 176.74M | 177.26M | 177.76M | 178.25M | 178.71M | 179.17M | 179.63M | 180M | 156.13M | 156.93M | 157.48M | 158M | 158.51M | 159.01M | 159.5M | 164.5M | 165.16M | 24.43M |
Common Stock | 1.53M | 1.52M | 1.52M | 1.52M | 1.52M | 1.5M | 1.5M | 1.41M | 1.2M | 1.19M | 1.19M | 1.19M | 1.02M | 1.02M | 1.02M | 1.02M | 1.02M | 914K |
Retained Earnings | -1.92B | -1.92B | -1.92B | -1.92B | -1.92B | -1.91B | -1.91B | -1.9B | -1.87B | -1.83B | -1.8B | -1.78B | -1.73B | -1.68B | -1.61B | -1.56B | -1.51B | -1.45B |
Comprehensive Income | -1K | 1K | 13K | 40K | -8K | -6K | 13K | -1K | -6K | 9K | -19K | -57K | -11K | -8K | -6K | -4K | 41K | 121K |
Shareholders Equity | -27.26M | -28.45M | -33.65M | -40.01M | -37.94M | -33.77M | -33.97M | -27.79M | -39.28M | -11.43M | 13.57M | 22.45M | -21.74M | 23.96M | 77.57M | 118.84M | 160.11M | 196.22M |
Total Investments | 24.12M | 31.41M | 33.48M | 45.15M | 48.96M | 51.07M | 51.73M | 42.55M | 19.78M | 32.93M | 69.49M | 71.31M | 34.93M | 55M | 67.04M | 43.25M | 66.5M | 106.73M |